PentaBind
PrivateLast Round
Grant
Jul 1, 2024
Total Funding Raised
$260,000
Company Overview
PentaBind is a biotechnology company that develops precision aptamer therapeutics intended to treat unmet diseases. The company uses artificial intelligence and an integrated wet laboratory to design aptamers that can be used to detect and target almost any molecule of interest, with an initial focus on oncology.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PentaBind Comps
Public and private peers based on sector, stage, and business model.
PentaBind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2024 | ||||
| Pre Seed | Jan 11, 2024 | ||||
| Accelerator | Oct 1, 2023 | ||||
| Accelerator | Dec 1, 2022 |
Key People
Founding team and executive leadership
PentaBind Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KQ Labs | Accelerator, Pre Seed |
| Hoxton Ventures | Pre Seed |
| Panacea Stars | Accelerator |
| Innovate UK | Grant |
| The Francis Crick Institute | Accelerator |
| LifeArc | Accelerator |
| Next Sequence | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 27, 2024
Grew 67% QoQ, from 6 to 10 employees.
- Jul 1, 2024
$60K grant received from Innovate UK.
PentaBind Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PentaBind's valuation, stock price, and market status.
